Invokana Warnings Continue to Increase
The Food and Drug Administration has issued additional warnings regarding the use of prescription drugInvokana. The canagliflozin, Invokana, is prescribed to treat Type 2 diabetes and was approved by the FDA in 2013. The medication is prescribed by physicians to lower the blood sugar levels in individuals that suffer from Type 2 diabetes. In…